Footnote 14 — Earnings Per Share

The computations of the weighted average shares outstanding for the periods indicated are as follows (in millions):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2017		2016		2017		2016
Weighted-average shares outstanding		489.6		482.3		485.2		396.9
Share-based payment awards classified as participating securities		0.8		1.7		1.1		1.4

Basic weighted-average shares outstanding		490.4		484.0		486.3		398.3
Dilutive securities (1)		1.1		2.2		1.6		1.8

Diluted weighted-average shares outstanding		491.5		486.2		487.9		400.1

(1)	For the three and nine months ended September 31, 2017 and 2016 the amount of potentially dilutive securities that are excluded because their effect would be anti-dilutive are not material.

At September 30, 2017, there were approximately 2.5 million shares of the Company’s common stock that had not been issued to the former holders of Jarden shares who are exercising their right to judicial appraisal under Delaware law. Absent consent by the Company, these dissenting shareholders are no longer entitled to the merger consideration, but are instead entitled only to the judicially determined fair value of their shares, plus interest accruing from the date of the Jarden Acquisition, payable in cash (see Footnote 18).